Back to Journals » Cancer Management and Research » Volume 14

Review

Update on Lorlatinib: Role in Reducing the Risk of Disease Progression in ALK-Positive NSCLC

       
Total article views   HTML views PDF downloads Totals
9,343 Dovepress* 7,125+ 371 7,496
PubMed Central* 2,218 479 2,697
Totals 9,343 850 10,193
*Since 26 February 2022
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 1 2 3

View citations on PubMed Central and Google Scholar